The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
about
The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated SymptomatologySecondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to GlomerulosclerosisMetabolic syndrome and the hepatorenal reflexAngiotensin II down-regulates nephrin-Akt signaling and induces podocyte injury: roleof c-Abl.Obesity and Kidney Disease: Hidden Consequences of the Epidemic.Obesity in the intensive care unit: risks and complications.Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisDohaekseunggi-tang extract inhibits obesity, hyperlipidemia, and hypertension in high-fat diet-induced obese mice.The pathophysiology of hypertension in patients with obesity.Renal hyperfiltration as a novel marker of all-cause mortality.Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)Metabolic syndrome and the hepatorenal reflex.Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review.Effects of weight reduction regimens and bariatric surgery on chronic kidney disease in obese patients.Novel targets of antifibrotic and anti-inflammatory treatment in CKD.New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes.Hypertension in pediatric patients with chronic kidney disease: management challenges.Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.The NLPR3 inflammasome and obesity-related kidney disease.Role of c-Abl and nephrin in podocyte cytoskeletal remodeling induced by angiotensin II.Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.Obesity and kidney disease: Hidden consequences of the epidemic.Obesity and kidney disease: hidden consequences of the epidemic.Obesity and kidney disease: hidden consequences of the epidemic.Obesity and kidney disease: hidden consequences of the epidemic.Fat Mass Is Associated With Cystatin C and Estimated Glomerular Filtration Rate in Adolescents With Type 1 Diabetes.Obesity and kidney disease: hidden consequences of the epidemic
P2860
Q26746157-97344951-C2A1-49E3-873B-E31356C25D61Q26752830-0F31C350-2D51-45FE-8542-A4B4DACEFFE1Q28073645-4B48F470-1DC2-4E6B-9007-33DAACA2E452Q30009079-95A4FD2E-68C6-49D4-958C-59148AD9FD33Q30235506-2B13AF30-31E0-4C0A-8AF9-5597324422E1Q30251547-159A918E-B966-479C-8FC6-EA575BE5805FQ30301249-0F43852B-07AD-47BD-8479-59238042F491Q33932951-CC7E2616-C353-4FC4-B816-A6479DC1C9DBQ34320386-2DCB4C68-D964-41A5-A603-52BA8CD2C5CAQ35021492-695667CD-6771-4B18-AA93-9D29BC0A2637Q35658570-14C6A8D1-24B1-41EF-8C46-F93F145CE7FBQ37312231-453D7393-F869-4158-B020-213467FA8C40Q37604638-A9067584-383B-4791-87C5-DF6D1B40F006Q37709360-D3BB2D6F-0CEF-453B-83C9-771F3A4223AFQ38119204-ED4B8B9D-827F-4CB8-BE9D-811BF8AAD4C0Q38198872-2B31888F-27A9-4A77-B1C9-76BCDBFC8C93Q38845433-5DB1C8AC-F0AD-405B-8409-A18DD8FF714EQ39039079-8AAB5184-759D-42C1-9080-39609C361C73Q41200646-94A47E36-779F-4A40-8E54-77C1591CB1FFQ46941041-22E56162-3E5D-41E6-865A-DB703A4E42C4Q47130640-285DB7B3-BACB-4164-B394-08309CF44993Q50130137-3246037B-A04B-4301-8368-D6494AB1F3A6Q52715295-5F3C9B9B-2118-4598-B1BF-4A2C1BDD19A0Q52720558-9306A2E5-D4BE-4FDA-82AB-9C518A33CABAQ52906732-45BFA918-3A95-45B6-906F-01F43437116DQ53081563-0A189A61-1061-43A2-B60A-BBE4BAF64E4CQ53347632-33B32832-AF9D-4B83-A667-1B529CB5679AQ55036313-A75B74B2-ADFD-4F12-B97F-0595711EBA8EQ57771331-26436C56-F2B4-41A1-A2F7-82C97EA5033A
P2860
The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
@en
type
label
The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
@en
prefLabel
The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
@en
P1476
The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
@en
P2093
Christiane Rüster
Gunter Wolf
P356
10.1016/J.SEMNEPHROL.2012.12.002
P577
2013-01-01T00:00:00Z